Si prevede che il mercato degli indicatori della temperatura sanguigna crescerà da 216,05 milioni di dollari nel 2021 a 504,37 milioni di dollari entro il 2028; si stima registrerà un CAGR del 12,9% dal 2021 al 2028.
Gli indicatori della temperatura del sangue sono piccoli dispositivi medici o soluzioni che aiutano ad aumentare la sicurezza del sangue trasportando in modo efficace ed efficiente sangue e componenti del sangue. Questi indicatori forniscono una prova verificabile che il sangue viene conservato e trasportato secondo gli standard normativi, riducendo ulteriormente lo spreco di sangue.
Il rapporto fornisce approfondimenti e analisi approfondite del sangue mercato degli indicatori di temperatura, sottolineando vari parametri come le tendenze del mercato, i progressi tecnologici e le dinamiche di mercato. Fornisce inoltre l’analisi del panorama competitivo dei principali attori del mercato e l’impatto della pandemia COVID-19 sul mercato degli indicatori della temperatura sanguigna in tutte le principali regioni. La pandemia di COVID-19 ha sconvolto le condizioni socioeconomiche di vari paesi in tutto il mondo. Secondo le statistiche dell’OMS del 2021, gli Stati Uniti sono il paese più colpito al mondo a causa della pandemia di COVID-19, con il maggior numero di casi di COVID-19. L’elevato numero di casi ha ostacolato l’economia del Nord America, in particolare quella degli Stati Uniti. La pandemia di COVID-19 ha portato a cambiamenti tecnologici cruciali per fornire una migliore assistenza medica. A causa della diffusione della SARS-CoV-2, molte città vengono chiuse, con conseguente annullamento delle cure da parte di medici/chirurghi. La pandemia di COVID-19 ha influenzato la produzione e la fornitura di indicatori della temperatura sanguigna a causa dell’interruzione della catena di approvvigionamento a livello globale. Inoltre, gli operatori sanitari stanno dando priorità alle procedure di emergenza e annullando tutti gli interventi chirurgici elettivi per prevenire la diffusione del coronavirus.
Nel 2020, la Food and Drug Administration (FDA) ha consentito l’uso d’emergenza del plasma convalescente per il trattamento dei pazienti affetti da COVID-19, con conseguente aumento delle donazioni di sangue. Inoltre, si prevede che la presenza dei principali attori del mercato e le loro varie collaborazioni strategiche nel mercato degli indicatori della temperatura sanguigna supporteranno la crescita del mercato. Timestrip, ad esempio, lo sviluppatore della tecnologia degli indicatori intelligenti, sta lanciando una gamma completamente nuova con due indicatori elettronici di temperatura. Questi indicatori saranno fondamentali per monitorare lo stoccaggio e il trasporto sicuri di vari beni, tra cui prodotti farmaceutici, vaccini, assistenza sanitaria, prodotti alimentari, adesivi e inchiostri. Pertanto, la pandemia di COVID-19 ha influenzato negativamente il mercato degli indicatori della temperatura sanguigna.
In base alla regione, il mercato degli indicatori della temperatura sanguigna è segmentato in Nord America, Europa, Asia Pacifico. , Medio Oriente e Medio Oriente Africa e Sud & America Centrale.
Approfondimenti strategici
Regioni redditizie per il mercato degli indicatori della temperatura sanguigna
Approfondimenti di mercato
L'aumento delle trasfusioni e delle donazioni di sangue guida il mercato degli indicatori della temperatura sanguigna
La trasfusione di sangue è una delle procedure comunemente utilizzate in ambito sanitario, che aiuta a mantenere il livello ematico dei pazienti. Esistono varie condizioni croniche, procedure chirurgiche e casi di trauma che richiedono trasfusioni di sangue in modo che i pazienti possano sopravvivere senza effetti collaterali dovuti ai bassi livelli ematici. Condizioni mediche, tra cui talassemia, cancro del sangue, anemia falciforme, anemia e casi chirurgici e traumatici, portano alla perdita di sangue e richiedono una trasfusione di sangue. Secondo la Croce Rossa americana, ogni anno negli Stati Uniti vengono trasfusi circa 16 milioni di componenti del sangue. Inoltre, l'anemia falciforme colpisce 90.000-100.000 persone negli Stati Uniti; Ogni anno nascono circa 1.000 bambini affetti da questa malattia. Pertanto, la crescente prevalenza di malattie croniche ha creato la domanda di trasfusioni di sangue, che dovrebbe stimolare la crescita del mercato degli indicatori di temperatura del sangue.
Dopo la raccolta, il sangue dovrebbe essere immagazzinati e trasportati in condizioni e temperature specifiche. Se il sangue viene conservato e trasportato al di fuori dell’intervallo di temperatura specifico per un periodo prolungato, perde la sua capacità di trasportare ossigeno, il che può causare seri problemi. Inoltre, esiste il rischio di grave contaminazione batterica se il sangue è esposto a temperature calde. Gli indicatori della temperatura del sangue svolgono un ruolo importante nel mantenimento delle condizioni e della temperatura richieste per il trasporto sicuro e affidabile del sangue e dei suoi componenti. Riduce le possibilità di deterioramento del sangue monitorando attentamente la temperatura e mantenendo il sangue al sicuro durante il trasporto. Pertanto, l'aumento delle trasfusioni di sangue, delle donazioni di sangue e la crescente domanda di trasporto sicuro del sangue e dei suoi componenti creano domanda di indicatori della temperatura del sangue, che guidano la crescita del mercato.
Prodotto Approfondimenti basati sul tipo
In base al tipo di prodotto, il mercato degli indicatori di temperatura del sangue è segmentato in da 2°C a 4°C, da 5°C a 7°C e sopra 7°C. Nel 2021, il segmento da 2°C a 4°C rappresentava la quota di mercato maggiore. La posizione di mercato di questo segmento è aumentata grazie al suo maggiore utilizzo durante il trasporto di sangue su lunghe distanze. Ad esempio, secondo le principali linee guida europee e americane, la temperatura delle sacche per RBC deve essere compresa tra 1°C e 6°C durante la conservazione e tra 1°C e 10°C durante il trasporto.
Mercato degli indicatori della temperatura sanguigna, per tipo di prodotto: 2020 e 2028
Approfondimenti sull'utente finale
In base all'utente finale, il mercato degli indicatori della temperatura del sangue è segmentato in ospedali, banche del sangue e altri. Il segmento ospedaliero ha dominato il mercato nel 2021.
Gli operatori del mercato degli indicatori della temperatura del sangue adottano strategie organiche come il lancio e l'espansione dei prodotti per espandere la propria presenza e il portafoglio prodotti a livello globale.< /p>
Profili aziendali
- Elitech
- Thero Fisher Scientific Inc.
- Sercalia
- Gruppo Ellab
- Zebra Technologies Corporation
- Lisaline Lifesceinces Technologies
- Stream Peak International PTE Ltd
- 3M
- DeltaTrak Inc.
- TimeStrip UK Ltd
; '   ; &n bsp;
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Blood Temperature Indicators are small medical devices or solutions which helps in increasing the blood safety and allows effective and efficient transportation of blood and its components. These indicators provide auditable proof that blood is stored and transported as per regulatory standards this further reduces blood waste.
Increase in blood transportation and donation owing to increasing awareness and rising prevalence of various conditions such as chronic disorders, surgeries trauma cases along with accuracy of blood temperature indicator are the most significant factors responsible for the overall market growth.
Based on product type, 2°C to 4°C segment took the forefront lead in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.
The hospital segment dominated the global blood temperature indicator market and accounted for the largest revenue of US$ 90.35 Mn in 2021.
Elitech; Thermo Fisher Scientific Inc.; Ellab Group; Zebra Technologies Corporation; LisaLine Lifesciences Technologies; Stream Peak International Pte Ltd.; 3M; TimeStrip UK Ltd. are among the leading companies operating in the global blood temperature indicator market
Global blood temperature indicator market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for blood temperature indicator market. The US is estimated to hold the largest share in the blood temperature indicator market during the forecast period. The presence of top players and increased demand for blood transfusion are the contributing factors for the regional growth. Additionally, improvements in healthcare infrastructure, increase in blood banks, high adoption rate and increased awareness among people regarding blood donation are the key factor responsible for the Asia-Pacific regional growth for blood temperature indicator accounting fastest growth of the region during the coming years.
- Elitech
- Thermo Fisher Scientific Inc.
- Sercalia
- Ellab Group
- Zebra Technologies Corporation
- Lisaline Lifesciences Technologies
- Stream Peak International PTE Ltd
- 3M
- DeltaTrak Inc
- TimeStrip UK Ltd
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
May 2022
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
May 2022
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2022
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2022
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2022
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2022
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2022
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
May 2022
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)